Telogen Effluvium After COVID-19 Vaccination Among Public in Saudi Arabia

January 2022 in “ Journal of family medicine and primary care ”

Mana Alharbi

telogen effluvium COVID-19 vaccination hair fall preexisting conditions stress COVID-19 infection

TLDR Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

In a 2021 cross-sectional study involving 991 participants in Saudi Arabia, it was found that 67.6% experienced hair fall after receiving COVID-19 vaccines. However, only 27.6% of these cases were directly linked to the vaccine, with the rest having preexisting conditions or previous hair fall experiences. The study also noted that post-vaccination hair fall was significantly higher in females and in those who had not previously experienced hair fall. The role of COVID-19 infection and stress related to the infection and vaccine were also suggested as potential causes of hair fall. The study emphasizes the need for healthcare professionals to consider the COVID-19 vaccine as a potential cause of hair loss.

View this study on journals.lww.com →

Discuss this study in the Community →

Cited in this study

16 / 16 results

research The Role of SARS-CoV-2 Infection and Its Vaccines in Various Types of Hair Loss

14 citations , April 2022 in “Dermatologic Therapy”

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations , December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , December 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations , October 2021 in “Journal of The American Academy of Dermatology”

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations , August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients

18 citations , May 2021 in “Experimental Dermatology”

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

research A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19

14 citations , March 2021 in “Journal of The American Academy of Dermatology”

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , December 2020 in “Journal of the European Academy of Dermatology and Venereology”

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

research Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review

101 citations , August 2020 in “Dermatologic therapy”

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

research Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications

31 citations , June 2020 in “Dermatologic Therapy”

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

research Telogen Effluvium: A Review of the Literature

40 citations , May 2020 in “Cureus”

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

research Telogen Effluvium: A Comprehensive Review

56 citations , August 2019 in “Clinical, Cosmetic and Investigational Dermatology”

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

research Female Pattern Hair Loss

11 citations , July 2018 in “AJGP”

research Evaluation and Management of the Hair Loss Patient in the Primary Care Setting

2 citations , December 2015 in “Primary Care: Clinics in Office Practice”

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

research Telogen Effluvium: A Review

70 citations , January 2015 in “Journal of Clinical and Diagnostic Research”

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

5 / 5 results

research Diffuse Hair Loss

January 2022 in “Elsevier eBooks”

The document's conclusion cannot be summarized because it is not readable or understandable.

research Hair Loss

August 2021 in “Pharmacy Today”

The document's conclusion about hair loss cannot be determined.

research Treatment of Female Pattern Hair Loss with Combination Therapy

2 citations , December 2018 in “Seminars in Cutaneous Medicine and Surgery”

research A Review on Hair Loss and Damage

January 2016

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

research Viviscal: An Answer for Hair Loss in Women?

August 2013 in “Pharmacy Today”

Viviscal may modestly improve hair loss in women without adverse effects.